Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISIONAIRE: Edoxaban vs Warfarin vs No Anticoagulation in AF with Severe CKD
NCT06402851Phase 4Recruiting
- Sponsor
- Hospital Sírio-Libanês
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Hospital Sírio-Libanês. Started Dec 2024; status: recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT06402851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402851.